Literature DB >> 3947541

Discoid lupus erythematosus-like lesions in an autosomal form of chronic granulomatous disease.

J F Stalder, B Dreno, B Bureau, J Hakim.   

Abstract

Chronic granulomatous disease (CGD) is characterized by a bactericidal defect involving the oxidative metabolism of polymorphonuclear leukocytes (PML) and is most often transmitted as an X-linked trait. The cutaneous features of this disorder include infections and lupus-like rashes. These have been described in female carriers as well as in males with the disease. Two cases of siblings presenting an autosomal form of CGD syndrome, with lupus-like cutaneous manifestations, are reported here.

Entities:  

Mesh:

Year:  1986        PMID: 3947541     DOI: 10.1111/j.1365-2133.1986.tb02805.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease.

Authors:  C B Foster; T Lehrnbecher; F Mol; S M Steinberg; D J Venzon; T J Walsh; D Noack; J Rae; J A Winkelstein; J T Curnutte; S J Chanock
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

2.  Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.

Authors:  Tiina Kelkka; Deborah Kienhöfer; Markus Hoffmann; Marjo Linja; Kajsa Wing; Outi Sareila; Malin Hultqvist; Essi Laajala; Zhi Chen; Júlia Vasconcelos; Esmeralda Neves; Margarida Guedes; Laura Marques; Gerhard Krönke; Merja Helminen; Leena Kainulainen; Peter Olofsson; Sirpa Jalkanen; Riitta Lahesmaa; M Margarida Souto-Carneiro; Rikard Holmdahl
Journal:  Antioxid Redox Signal       Date:  2014-07-29       Impact factor: 8.401

3.  Chronic Granulomatous Disease First Diagnosed in Adulthood Presenting With Spinal Cord Infection.

Authors:  Philipp Schwenkenbecher; Alexandra Neyazi; Frank Donnerstag; Felix C Ringshausen; Roland Jacobs; Matthias Stoll; Philip Kirschner; Florian Peter Länger; Emil Valizada; Stefan Gingele; Florian Wegner; Kurt-Wolfram Sühs; Martin Stangel; Thomas Skripuletz
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.